Jacob W.

Jacob W. is currently a Visiting Researcher at the Broad Institute of MIT and Harvard, focusing on Myeloid-Derived Suppressor Cells in inflammatory environments. Additionally, Jacob is affiliated with Harvard Medical School and Massachusetts General Hospital, investigating MDSCs in sepsis pathology. With a strong background in cancer research, Jacob served as a Clinical Researcher in Thoracic Oncology and held roles such as Founder & Co-President of Atlas Strategy Group and 1st Student Body Vice President of Diversity, Equity, and Inclusion at UC Berkeley’s Haas School of Business. Educational achievements include a B.A. in Immunology and Molecular Medicine and a B.S. in Business Administration from UC Berkeley, among other notable academic credentials.